Whitepaper , Orphan Rare Diseases , Clinical Trial Manufacturing , Formulation Development

Accelerating the Developing of Orphan Drugs for Rare Diseases


Worldwide over 300 million people are living with identified rare diseases. This white paper will discuss four principal CMC challenges for the developers of orphan drugs and the potential solutions that are emerging.